Literature DB >> 9508323

Evaluation of the E test for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from patients with long-term bladder catheterization.

G Di Bonaventura1, E Ricci, N Della Loggia, G Catamo, R Piccolomini.   

Abstract

The E test was evaluated in comparison with reference agar methods (National Committee for Clinical Laboratory Standards) for the susceptibility testing of 248 Pseudomonas aeruginosa isolates from bladder-catheterized patients against nine antibiotics. The E-test MICs correlated well with those determined by the agar dilution and disk diffusion reference methods (88 and 92.5% within 1 log2 dilution step, respectively), confirming that the E test is a reliable method for the determination of MICs of antibiotics for catheterization-associated P. aeruginosa isolates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9508323      PMCID: PMC104636          DOI: 10.1128/JCM.36.3.824-826.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria.

Authors:  C N Baker; S A Stocker; D H Culver; C Thornsberry
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents.

Authors:  R Piccolomini; G Di Bonaventura; G Catamo; F Carbone; M Neri
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

3.  Clinical laboratory evaluation of the Abbott MS-2 automated antimicrobial susceptibility testing system: report of a collaborative study.

Authors:  C Thornsberry; J P Anhalt; J A Washington; L R McCarthy; F D Schoenknecht; J C Sherris; H J Spencer
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

4.  The nationwide nosocomial infection rate. A new need for vital statistics.

Authors:  R W Haley; D H Culver; J W White; W M Morgan; T G Emori
Journal:  Am J Epidemiol       Date:  1985-02       Impact factor: 4.897

5.  Comparison of five methods, including the PDM Epsilometer test (E test), for antimicrobial susceptibility testing of Pseudomonas aeruginosa.

Authors:  L F Joyce; J Downes; K Stockman; J H Andrew
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

6.  Evaluation of E-Test for determination of antimicrobial MICs for Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  E F Marley; C Mohla; J M Campos
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

7.  Epidemiology of quinolone resistance. Eastern hemisphere.

Authors:  J Turnidge
Journal:  Drugs       Date:  1995       Impact factor: 9.546

8.  Reduction of mortality associated with nosocomial urinary tract infection.

Authors:  R Platt; B F Polk; B Murdock; B Rosner
Journal:  Lancet       Date:  1983-04-23       Impact factor: 79.321

Review 9.  Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies.

Authors:  D N Fish; S C Piscitelli; L H Danziger
Journal:  Pharmacotherapy       Date:  1995 May-Jun       Impact factor: 4.705

10.  Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa.

Authors:  N Masuda; S Ohya
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

View more
  5 in total

1.  Evaluation of the E test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  B Balke; M Hogardt; S Schmoldt; L Hoy; H Weissbrodt; S Häussler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-01       Impact factor: 3.267

2.  Discrepancy in antimicrobial susceptibility test results obtained for oral streptococci with the Etest and agar dilution.

Authors:  Eiman M Mokaddas; Nathaneal O Salako; Leeba Philip; Vincent O Rotimi
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

3.  Evaluation of a novel automated chemiluminescent assay system for antimicrobial susceptibility testing.

Authors:  Isao Manome; Masanari Ikedo; Yoshihiko Saito; Keiko Kumura Ishii; Mitsuo Kaku
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

4.  Occurrence, antimicrobial susceptibility, and pathogenic factors of Pseudomonas aeruginosa in canine clinical samples.

Authors:  Jasmine Hattab; Francesco Mosca; Cristina Esmeralda Di Francesco; Giovanni Aste; Giuseppe Marruchella; Pierluigi Guardiani; Pietro Giorgio Tiscar
Journal:  Vet World       Date:  2021-04-23

5.  Mutations causing low level antibiotic resistance ensure bacterial survival in antibiotic-treated hosts.

Authors:  Jakob Frimodt-Møller; Elio Rossi; Janus Anders Juul Haagensen; Marilena Falcone; Søren Molin; Helle Krogh Johansen
Journal:  Sci Rep       Date:  2018-08-21       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.